Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
18,786 total articles
Townsquare Media, a community-focused digital and broadcast media company, announced it will release its first quarter 2026 financial results on May 11, 2026, before the market opens. The company is hosting a conference call to discuss the results, providing investors with insights into its digital advertising, marketing solutions, and radio broadc…
Sinclair, Inc. announced that it will release its first quarter 2026 earnings results on April 30, 2026, at 4:00 p.m. Eastern Time, with a subsequent conference call to discuss the results. The event will be webcast live on the company's website and will include an opportunity for media questions post-call, ensuring transparency and timely communic…
LGI Homes announced the closing of 451 homes in March 2026 and 916 homes in the first quarter of 2026, including some leased single-family rental homes. The company operates 142 active selling communities across 36 markets in 21 states and will release its first quarter earnings on April 28, 2026, followed by a conference call.
Sify Technologies Limited, a leading Indian digital ICT solutions provider listed on NASDAQ, will announce its unaudited IFRS financial results for the fiscal year ending March 31, 2026, on April 13, 2026. The company will also host a conference call with senior executives for further insights into the financial results. Sify provides cloud, data c…
OneMedNet Corporation announced robust financial results for 2025, including a 329% year-over-year revenue increase driven by its AI-driven iRWD™ platform powered by Palantir Foundry. The company has reduced total liabilities by 74%, improved its equity position significantly, and secured promising pilot and subscription opportunities, projecting s…
Organogenesis Holdings Inc. announced the successful completion of a randomized controlled trial demonstrating that PuraPly® AM combined with standard care significantly improves wound closure in diabetic foot ulcers compared to standard care alone. This achievement strengthens the clinical evidence for PuraPly® AM and is expected to support its in…
FTI Consulting, Inc. has appointed three senior managing directors—James Chapman, Steve Dyson, and Franz Wentzel—into its Australian Transformation practice, expanding its mining and resources business improvement team. These additions bring extensive leadership experience from major consulting firms and mining operations, strengthening FTI's capab…
Gaia, the world's largest conscious streaming platform, has been recognized by Newsweek as one of the 15 Best Mindfulness & Wellness Apps for 2026. The company offers over 10,000 exclusive health, wellness, and spiritual growth videos to more than 900,000 members worldwide. Gaia also recently launched AI Guides that have driven strong engagement an…
Telix Pharmaceuticals Limited announced robust Q1 2026 financial results with 24% year-over-year revenue growth to $230 million and confirmed FY 2026 guidance between $950 million and $970 million. The company highlighted progress in its therapeutic pipeline, including successful completion of key safety objectives for its TLX591-Tx prostate cancer…
Celldex Therapeutics has closed its underwritten public offering of common stock, including full exercise of underwriters’ option, resulting in gross proceeds of approximately $345 million. The offering was conducted under an existing shelf registration with the SEC. The funds are aimed to support the advancement of Celldex's clinical-stage pipelin…
Jena Acquisition Corporation II, a US-listed blank check company on the NYSE, announced it is currently non-compliant with the NYSE's minimum public stockholder requirement of 300 shareholders. The company plans to submit a business plan to return to compliance within 18 months primarily by completing a de-SPAC transaction. During the cure period, …
Midland States Bancorp, Inc., a community-based financial holding company, announced it will release its first quarter 2026 financial results after market close on April 23, 2026, accompanied by an investor presentation available on its website.
Inhibikase Therapeutics announced the issuance of non-qualified stock options totaling 685,718 shares to five newly hired non-executive employees as part of its 2026 Inducement Equity Plan. The options are priced at $1.68 per share, matching the closing stock price on the grant date, with a 10-year term and a vesting schedule extending over four ye…
Wix.com Ltd. successfully concluded its modified Dutch auction tender offer, purchasing 17.58 million shares (29.7% of outstanding shares) at $92.00 per share for approximately $1.617 billion. This substantial share buyback highlights the company's confidence in its long-term strategy and commitment to returning value to shareholders amid ongoing d…
TELUS Digital, a subsidiary of TELUS Corporation, emphasizes the critical role of precise multi-sensor data labeling—combining LiDAR, radar, and camera data—in developing safe, production-ready autonomous vehicle perception systems. Recognized as a leader by Everest Group, TELUS Digital supports enterprise AV teams with scalable, human-in-the-loop …
ArcelorMittal has issued a convening notice for its Annual General Meeting and Extraordinary General Meeting on May 5, 2026. Key agenda items include the re-election of current board members, the nomination of a new director, Mr. Roy Harvey, former President and CEO of Alcoa, and renewal of board authorization to issue and cancel shares. Relevant d…
STMicroelectronics announced that it will release its first quarter 2026 earnings before the European stock market opens on April 23, 2026. The company will also host a conference call with key stakeholders to discuss the financial results and business outlook. The results and webcast will be accessible on their website.
Denali Therapeutics announced Takeda's decision to terminate their collaboration on DNL593, a progranulin replacement therapy for frontotemporal dementia linked to GRN mutations. Denali will continue clinical development independently and plans to report Phase 1/2 study results by the end of 2026. The investigational therapy uses Denali's Transport…
Impact BioMedical Inc. disclosed a 'going concern' qualification in its 2025 10-K audit report highlighting financial uncertainties. Despite this, the company continues with its planned strategic merger with Dr. Ashley's Ltd., anticipated by July 1, 2026.
WW International, Inc. announced the departure of CEO Tara Comonte and has established an Office of the CEO led by senior executives during the search for a permanent successor. The Board formed a Transition Committee to oversee leadership changes and governance matters. Additionally, Debra Cotter was appointed chief legal officer and secretary. Th…
RCM Technologies, Inc. announced robust financial results for the fourth quarter and fiscal year ending January 3, 2026, demonstrating solid growth in revenue, gross profit, and net income compared to the prior year and quarter. The company experienced notable increases in both GAAP and non-GAAP metrics, including a 12.4% revenue growth quarter-ove…
AEON Biopharma announced inducement grants totaling over 990,000 restricted stock units to newly appointed CFO John Bencich. These equity awards are designed to incentivize his employment and align his interests with the company, with vesting tied to his service and AEON's regaining compliance with NYSE American listing standards. The company is fo…
AEON Biopharma announced it received an additional notice from NYSE American indicating non-compliance with an additional listing standard due to stockholders' equity deficit and continued losses. Although this does not immediately impact its listing or previously established compliance plan, failure to regain compliance by August 3, 2026, could le…
Intellia Therapeutics announced inducement grants of 67,150 restricted stock units to 13 new employees as a material inducement to employment under its 2024 Inducement Plan. The RSUs vest over three years and were granted outside the company's stockholder-approved equity plans under Nasdaq Listing Rule 5635(c)(4).
Syndax Pharmaceuticals granted inducement stock options for 228,500 shares to eight new employees as part of its 2023 Inducement Plan. These options vest over four years and are aimed at attracting and retaining talent to support its cancer therapy pipeline and ongoing clinical trials.
